I. Houas
发表
Vaccine breakthrough hypoxemic COVID-19 pneumonia in patients with auto-Abs neutralizing type I IFNs
Mark S. Anderson,
Chun Jimmie Ye,
Gabriela K. Fragiadakis,
2022,
Science immunology.
Siti Zubaidah Othman,
Karl Erik Müller,
Jose M. Mandei,
2021,
The Lancet Infectious Diseases.
S. Yatouji,
H. Ben Mansour,
D. Dridi,
2011,
Annals of Clinical Microbiology and Antimicrobials.
Inserm,
Shana M Augustin,
C. Charpentier,
2020,
Clinical Microbiology and Infection.
C. A. Shaw,
Eglantine Ferrand Devouge,
Su Hwan Lee,
2022,
Critical Care.
C. Charpentier,
J. Timsit,
J. Hulot,
2022,
Critical Care.
M. de la Guardia,
M. L. Cervera,
M. Najjar,
2017,
Biomedical and environmental sciences : BES.
Siti Zubaidah Othman,
Eyvind W. Axelsen,
C. A. Shaw,
2022,
Influenza and other respiratory viruses.
L. Chekir‐Ghedira,
D. Barillier,
K. Ghédira,
2012,
Environmental Science and Pollution Research.
M. Najjar,
W. Douki,
L. Gaha,
2013
.
Andrew J. Oler,
Eglantine Ferrand Devouge,
P. Gregersen,
2023,
Genome Medicine.
V. Gaborieau,
A. Sommet,
R. Favory,
2021,
Fundamental & clinical pharmacology.
Andrew J. Oler,
Eglantine Ferrand Devouge,
P. Gregersen,
2023,
Genome Medicine.
Siti Zubaidah Othman,
C. A. Shaw,
Eglantine Ferrand Devouge,
2023,
Kidney International Reports.
Mark S. Anderson,
P. Gregersen,
R. Nussbaum,
2021,
Science Immunology.
C. Charpentier,
J. Timsit,
J. Hulot,
2023,
Journal of Clinical Immunology.
Siti Zubaidah Othman,
Eyvind W. Axelsen,
C. A. Shaw,
2022,
Influenza and other respiratory viruses.
J. Hasenauer,
C. Charpentier,
V. Gaborieau,
2023,
EClinicalMedicine.
Vaccine breakthrough hypoxemic COVID-19 pneumonia in patients with auto-Abs neutralizing type I IFNs
Mark S. Anderson,
Chun Jimmie Ye,
P. Gregersen,
2022,
Science Immunology.